Funds holding Adlai Nortye Ltd.
ISIN US00704R1095 · Cayman Islands · LEI 54930009TDXE4YQVKU60
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 1.8M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 219,665 | 1.5M $ | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 13,419 | 92.9K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 11,133 | 87.5K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 4,767 | 33K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 3,368 | 23.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Institutional managers
26 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Venrock Adviser, LLC | 3,212,731 | 22.2M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 2,897,857 | 20.1M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 1,265,231 | 8.8M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 877,846 | 6.1M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 681,775 | 4.7M $ | as of Mar 31, 2026 |
| Casdin Capital, LLC | 538,461 | 3.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 538,461 | 3.7M $ | as of Mar 31, 2026 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 414,852 | 2.9M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 209,259 | 1.4M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 164,748 | 1.1M $ | as of Mar 31, 2026 |
| UBS Group AG | 122,261 | 846K $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 120,156 | 831.5K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 117,909 | 815.9K $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 99,843 | 691 $ | as of Mar 31, 2026 |
| Tidal Investments LLC | 66,034 | 457K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 66,000 | 456.7K $ | as of Mar 31, 2026 |
| CANTOR FITZGERALD, L. P. | 40,310 | 278.9K $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 35,746 | 247.4K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 33,899 | 234.6K $ | as of Mar 31, 2026 |
| Persistent Asset Partners Ltd | 33,732 | 233.4K $ | as of Mar 31, 2026 |
| SmartHarvest Portfolios, LLC | 16,367 | 113.3K $ | as of Mar 31, 2026 |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | 15,000 | 103.8K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 11,133 | 77K $ | as of Mar 31, 2026 |
| EverSource Wealth Advisors, LLC | 4,794 | 33.2K $ | as of Mar 31, 2026 |
| ANTIPODES PARTNERS Ltd | 2,051 | 14.2K $ | as of Mar 31, 2026 |
Declared shareholders of Adlai Nortye Ltd.
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Cormorant Asset Management, LP and 1 other | 5.19 % | 2,897,857 | as of Mar 31, 2026 · SCHEDULE 13G |
| JIN YIN (BVI) LIMITED and 4 others | 2.90 % | 4,561,077 | as of Dec 31, 2023 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Adlai Nortye Ltd.". https://titelia.com/en/stocks/adlai-nortye-ltd-US00704R1095